DelveInsight’s “Vitiligo Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Vitiligo Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Vitiligo market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Vitiligo: An Overview
The American Vitiligo Research foundation defines Vitiligo as a condition in which the skin loses melanin, the pigment that determines skin color, hair, and eyes. If the cells that do not produce melanin die or no longer produce melanin, slowly growing white patches of irregular shapes appear on the skin. The typical lesions on the skin can be defined as milky white, non-scaly macules that are present with distinct margins.
The patient’s vitiligo evaluation entails a detailed history and a complete skin examination to assess disease severity and individual prognostic factors.
Vitiligo Market Key Facts
-
Vitiligo is a disease characterized by patches of skin depigmentation. Vitiligo’s global prevalence is 0.5%-2%, with reported rates varying geographically.
-
According to the Vitiligo Research Foundation, the average prevalence of vitiligo is between 0.5% to 2% of the world population, but local numbers may vary from 0.004% to 9.98%, depending on the region and age group.
-
As per the estimates by DelveInsight, the Vitiligo prevalence is higher in females than in males.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Vitiligo market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Vitiligo market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.
Vitiligo Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.
Vitiligo Epidemiology Segmentation
-
Total prevalent cases of Vitiligo
-
Total diagnosed and treatable cases of Vitiligo
-
Gender-specific cases of Vitiligo
-
Age-specific cases of Vitiligo
-
Type-specific Diagnosed Prevalent cases of Vitiligo
Vitiligo Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vitiligo market or expected to get launched during the study period. The analysis covers Vitiligo market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Vitiligo Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/vitiligo-market
Vitiligo Therapeutics Analysis
The treatments include phototherapy, topical and systemic immunosuppressants, and surgical techniques, which may help halt the disease, stabilize depigmented lesions, and stimulate repigmentation.
• In July 2022, the US FDA approved Incyte’s Opzelura (ruxolitinib) cream to treat nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Opzelura is a topical Janus kinase (JAK) inhibitor currently approved for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older.
Currently, there are approx. 22+ key companies which are developing therapies for Vitiligo.
Some of the key companies in the Vitiligo Therapeutic Market include
• Incyte Corporation
• Amgen
• Boston Pharmaceuticals
• Arcutis Biotherapeutics
• Pfizer
• Dermavant Sciences
• Clinuvel Pharmaceuticals
• Celgene
• TWi Biotechnology
• AXIM Biotechnologies
• Arrien Pharmaceuticals
• Sun Pharma Global FZE
And many others
Vitiligo Emerging Drugs Covered in the report include:
• Ruxolitinib (Incyte Corporation)
• AMG-714 (Amgen)
• ARQ-252
• AS012
• PF-06651600
And many more
Get More Detailed Insights Into the Emerging Therapies & Key Companies –
https://www.delveinsight.com/sample-request/vitiligo-market
The Vitiligo market is expected to grow in the coming years owing to the increase in the prevalent cases, a better understanding of the disease, the development of targeted treatment, and the launch of therapies.
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Vitiligo Competitive Intelligence Analysis
4. Vitiligo Market Overview at a Glance
5. Vitiligo Disease Background and Overview
6. Vitiligo Patient Journey
7. Vitiligo Epidemiology and Patient Population
8. Vitiligo Treatment Algorithm, Current Treatment, and Medical Practices
9. Vitiligo Unmet Needs
10. Key Endpoints of Vitiligo Treatment
11. Vitiligo Marketed Products
12. Vitiligo Emerging Therapies
13. Vitiligo Seven Major Market Analysis
14. Attribute Analysis
15. Vitiligo Market Outlook (7 major markets)
16. Vitiligo Access and Reimbursement Overview
17. KOL Views on the Vitiligo Market.
18. Vitiligo Market Drivers
19. Vitiligo Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/vitiligo-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Metastatic Cutaneous Squamous Cell Carcinoma Market
“Metastatic Cutaneous Squamous Cell Carcinoma Market” research report provides a detailed overview of the historical and forecasted epidemiology as well as the Metastatic Cutaneous Squamous Cell Carcinoma Market size, share, and trends in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan). Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/